Treatment of hypercholesterolaemia with PCSK-9 Inhibitors in Denmark. Assessment of real-life data; safety an extent of adverse effects after the first years of clinical use.
Event:
ESC Congress 2019
Topic:
Lipid-Lowering Agents
Session:
Preclinical pharmacotherapy
